Acacia Pharma reports excellent results from APD421 Phase 3 studies for administration of PONV Acacia Pharma announces positive Stage 3 outcomes with APD421 for the management of post-operative nausea & vomiting . The data generated demonstrated a statistically significant reduction in the incidence of PONV with APD421 in comparison to placebo in adult medical sufferers at moderate to risky of suffering PONV . This problem can be a clinically significant issue regardless of the availability of a variety of antiemetic medications medical info .
‘These findings have important implications for businesses and their managers. The data highlights the necessity for organizations to send out an unequivocal message to those in supervisory positions that these hostile and dangerous behaviors will never be tolerated,dawn Carlson ‘ said, Ph.D., study writer, professor of H and management. R. Gibson Seat of Organizational Advancement at the Hankamer College of Business at Baylor University, Waco. A supervisor’s abuse may include tantrums, rudeness, general public criticism and inconsiderate actions.